RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/17463090http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/17463090http://www.w3.org/2000/01/rdf-schema#comment"S3I-201 (NSC 74859) is a chemical probe inhibitor of Stat3 activity, which was identified from the National Cancer Institute chemical libraries by using structure-based virtual screening with a computer model of the Stat3 SH2 domain bound to its Stat3 phosphotyrosine peptide derived from the x-ray crystal structure of the Stat3beta homodimer. S3I-201 inhibits Stat3.Stat3 complex formation and Stat3 DNA-binding and transcriptional activities. Furthermore, S3I-201 inhibits growth and induces apoptosis preferentially in tumor cells that contain persistently activated Stat3. Constitutively dimerized and active Stat3C and Stat3 SH2 domain rescue tumor cells from S3I-201-induced apoptosis. Finally, S3I-201 inhibits the expression of the Stat3-regulated genes encoding cyclin D1, Bcl-xL, and survivin and inhibits the growth of human breast tumors in vivo. These findings strongly suggest that the antitumor activity of S3I-201 is mediated in part through inhibition of aberrant Stat3 activation and provide the proof-of-concept for the potential clinical use of Stat3 inhibitors such as S3I-201 in tumors harboring aberrant Stat3."xsd:string
http://purl.uniprot.org/citations/17463090http://purl.org/dc/terms/identifier"doi:10.1073/pnas.0609757104"xsd:string
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/author"Zhang S."xsd:string
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/author"Lawrence N.J."xsd:string
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/author"Sebti S.M."xsd:string
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/author"McLaughlin M.M."xsd:string
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/author"Blaskovich M.A."xsd:string
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/author"Guida W.C."xsd:string
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/author"Jove R."xsd:string
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/author"Turkson J."xsd:string
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/author"Yip M.L."xsd:string
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/author"Greedy B."xsd:string
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/author"Lawrence H.R."xsd:string
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/author"Siddiquee K."xsd:string
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/date"2007"xsd:gYear
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/name"Proc Natl Acad Sci U S A"xsd:string
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/pages"7391-7396"xsd:string
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/title"Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity."xsd:string
http://purl.uniprot.org/citations/17463090http://purl.uniprot.org/core/volume"104"xsd:string
http://purl.uniprot.org/citations/17463090http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/17463090
http://purl.uniprot.org/citations/17463090http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/17463090
http://purl.uniprot.org/uniprot/P42227#attribution-7FC65BDE26A45472EC7B06F400C414E4http://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/17463090
http://purl.uniprot.org/uniprot/#_A0A7I2V395-mappedCitation-17463090http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/17463090
http://purl.uniprot.org/uniprot/#_B4DNP0-mappedCitation-17463090http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/17463090